MX2021000411A - Composiciones oftalmicas que contienen una prostamida liberadora de oxido nitrico. - Google Patents
Composiciones oftalmicas que contienen una prostamida liberadora de oxido nitrico.Info
- Publication number
- MX2021000411A MX2021000411A MX2021000411A MX2021000411A MX2021000411A MX 2021000411 A MX2021000411 A MX 2021000411A MX 2021000411 A MX2021000411 A MX 2021000411A MX 2021000411 A MX2021000411 A MX 2021000411A MX 2021000411 A MX2021000411 A MX 2021000411A
- Authority
- MX
- Mexico
- Prior art keywords
- prostamide
- ophthalmic compositions
- compositions containing
- nitric oxide
- oxide releasing
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 title 2
- AQOKCDNYWBIDND-FTOWTWDKSA-N bimatoprost Chemical compound CCNC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)CCC1=CC=CC=C1 AQOKCDNYWBIDND-FTOWTWDKSA-N 0.000 title 1
- 229960002470 bimatoprost Drugs 0.000 title 1
- -1 6-(nitrooxy)- Chemical compound 0.000 abstract 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 abstract 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 abstract 1
- SHBUUTHKGIVMJT-UHFFFAOYSA-N Hydroxystearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OO SHBUUTHKGIVMJT-UHFFFAOYSA-N 0.000 abstract 1
- GONOPSZTUGRENK-UHFFFAOYSA-N benzyl(trichloro)silane Chemical compound Cl[Si](Cl)(Cl)CC1=CC=CC=C1 GONOPSZTUGRENK-UHFFFAOYSA-N 0.000 abstract 1
- 229940072106 hydroxystearate Drugs 0.000 abstract 1
- 229960003511 macrogol Drugs 0.000 abstract 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N n-hexanoic acid Natural products CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Ophthalmology & Optometry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Composiciones oftálmicas acuosas en forma de soluciones que comprenden éster (1S,2E)-3-[(1R,2R,3S,5R)-2-[(2Z)-7-(etilamino)-7- oxo-2-hepten-1-il]-3,5-dihidroxiciclopentil]-1-(2-feniletil)-2-pr open-1-ílico de ácido 6-(nitrooxi)hexanoico y 15-hidroxiestearato de macrogol como único agente solubilizante. Método para prepararlas.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18290082 | 2018-07-12 | ||
| PCT/EP2019/068511 WO2020011845A1 (en) | 2018-07-12 | 2019-07-10 | Ophthalmic compositions containing a nitric oxide releasing prostamide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2021000411A true MX2021000411A (es) | 2021-03-25 |
Family
ID=63012964
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2021000411A MX2021000411A (es) | 2018-07-12 | 2019-07-10 | Composiciones oftalmicas que contienen una prostamida liberadora de oxido nitrico. |
| MX2023007091A MX2023007091A (es) | 2018-07-12 | 2021-01-11 | Composiciones oftalmicas que contienen una prostamida liberadora de oxido nitrico. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023007091A MX2023007091A (es) | 2018-07-12 | 2021-01-11 | Composiciones oftalmicas que contienen una prostamida liberadora de oxido nitrico. |
Country Status (28)
| Country | Link |
|---|---|
| US (5) | US10688073B2 (es) |
| EP (2) | EP3593788B1 (es) |
| JP (4) | JP6672512B2 (es) |
| KR (1) | KR102861273B1 (es) |
| CN (2) | CN111249228B (es) |
| AR (1) | AR115734A1 (es) |
| AU (2) | AU2019300203B2 (es) |
| BR (1) | BR112021000240A2 (es) |
| CA (1) | CA3105989A1 (es) |
| CY (1) | CY1123706T1 (es) |
| DK (1) | DK3593788T3 (es) |
| ES (2) | ES2847853T3 (es) |
| HR (2) | HRP20251098T1 (es) |
| HU (2) | HUE052747T2 (es) |
| LT (1) | LT3593788T (es) |
| MA (2) | MA52258B1 (es) |
| MD (2) | MD3593788T2 (es) |
| MX (2) | MX2021000411A (es) |
| MY (1) | MY205816A (es) |
| PH (1) | PH12020552112A1 (es) |
| PL (2) | PL3593788T3 (es) |
| PT (1) | PT3593788T (es) |
| RS (2) | RS61348B1 (es) |
| SG (1) | SG11202100064WA (es) |
| SI (1) | SI3593788T1 (es) |
| SM (2) | SMT202500425T1 (es) |
| TW (1) | TWI839364B (es) |
| WO (1) | WO2020011845A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3593788B1 (en) * | 2018-07-12 | 2020-10-28 | Nicox S.A. | Ophthalmic compositions containing a nitric oxide releasing prostamide |
| US20240390390A1 (en) * | 2021-09-20 | 2024-11-28 | Nicox Sa | Nitric oxide releasing prostamide as neuroprotective agent |
| JP7665073B1 (ja) | 2024-04-05 | 2025-04-18 | ロート製薬株式会社 | 容器に収容してなる眼科用組成物 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2918891B1 (fr) * | 2007-07-20 | 2009-09-25 | Thea Sa Lab | Solution ophtalmique a base de prostaglandines sans conservateur |
| MX2010004211A (es) * | 2007-10-16 | 2010-06-30 | Sun Pharma Advanced Res Co Ltd | Composicion oftalmica que comprende una prostaglandina. |
| AR076731A1 (es) * | 2008-05-09 | 2011-07-06 | Pfizer | Prostamidas donadoras de oxido nitrico, uso de los mismos y composiciones farmaceuticas |
| GB2463565A (en) | 2008-09-12 | 2010-03-24 | Critical Pharmaceuticals Ltd | Improvements in the absorption of therapeutic agents across mucosal membranes or the skin |
| EP2566453A4 (en) * | 2010-05-07 | 2014-05-07 | Sun Pharma Advanced Res Co Ltd | NOVEL OPHTHALMIC COMPOSITIONS |
| FR2961694B1 (fr) | 2010-06-29 | 2013-01-25 | Thea Lab | Systeme de delivrance polymerique d'une solution non visqueuse a base de prostaglandine sans conservateur |
| JP2014522849A (ja) * | 2011-06-29 | 2014-09-08 | アラーガン インコーポレイテッド | ヒドロキシステアリン酸マクロゴール１５製剤 |
| AU2012291841A1 (en) | 2011-08-02 | 2014-02-06 | Cipla Limited | Pharmaceutical composition comprising ebastine and fluticasone |
| CN105012231A (zh) * | 2014-04-30 | 2015-11-04 | 四川科伦药物研究院有限公司 | 一种包含PGF2α衍生物的稳定性良好的眼用制剂及其制备方法 |
| CN105380901B (zh) * | 2015-11-18 | 2018-07-17 | 侯宇华 | 一种他氟前列素滴眼剂及其制备方法 |
| EP3593788B1 (en) * | 2018-07-12 | 2020-10-28 | Nicox S.A. | Ophthalmic compositions containing a nitric oxide releasing prostamide |
-
2019
- 2019-07-10 EP EP19185400.9A patent/EP3593788B1/en active Active
- 2019-07-10 CN CN202010145208.8A patent/CN111249228B/zh active Active
- 2019-07-10 HR HRP20251098TT patent/HRP20251098T1/hr unknown
- 2019-07-10 HU HUE19185400A patent/HUE052747T2/hu unknown
- 2019-07-10 SI SI201930023T patent/SI3593788T1/sl unknown
- 2019-07-10 MA MA52258A patent/MA52258B1/fr unknown
- 2019-07-10 AU AU2019300203A patent/AU2019300203B2/en active Active
- 2019-07-10 LT LTEP19185400.9T patent/LT3593788T/lt unknown
- 2019-07-10 ES ES19185400T patent/ES2847853T3/es active Active
- 2019-07-10 RS RS20210008A patent/RS61348B1/sr unknown
- 2019-07-10 MY MYPI2021000130A patent/MY205816A/en unknown
- 2019-07-10 PL PL19185400T patent/PL3593788T3/pl unknown
- 2019-07-10 MD MDE20200084T patent/MD3593788T2/ro unknown
- 2019-07-10 CN CN201910622356.1A patent/CN110237031B/zh active Active
- 2019-07-10 DK DK19185400.9T patent/DK3593788T3/da active
- 2019-07-10 MA MA48919A patent/MA48919B1/fr unknown
- 2019-07-10 PL PL20172140.4T patent/PL3718535T3/pl unknown
- 2019-07-10 AR ARP190101947A patent/AR115734A1/es unknown
- 2019-07-10 JP JP2019128085A patent/JP6672512B2/ja active Active
- 2019-07-10 BR BR112021000240-5A patent/BR112021000240A2/pt unknown
- 2019-07-10 KR KR1020217004141A patent/KR102861273B1/ko active Active
- 2019-07-10 SM SM20250425T patent/SMT202500425T1/it unknown
- 2019-07-10 MX MX2021000411A patent/MX2021000411A/es unknown
- 2019-07-10 SG SG11202100064WA patent/SG11202100064WA/en unknown
- 2019-07-10 HU HUE20172140A patent/HUE072927T2/hu unknown
- 2019-07-10 RS RS20250698A patent/RS67054B1/sr unknown
- 2019-07-10 MD MDE20210162T patent/MD3718535T2/ro unknown
- 2019-07-10 ES ES20172140T patent/ES3036636T3/es active Active
- 2019-07-10 EP EP20172140.4A patent/EP3718535B1/en active Active
- 2019-07-10 PT PT191854009T patent/PT3593788T/pt unknown
- 2019-07-10 CA CA3105989A patent/CA3105989A1/en active Pending
- 2019-07-10 WO PCT/EP2019/068511 patent/WO2020011845A1/en not_active Ceased
- 2019-07-10 US US16/508,028 patent/US10688073B2/en active Active
- 2019-07-10 SM SM20210034T patent/SMT202100034T1/it unknown
- 2019-07-10 TW TW108124327A patent/TWI839364B/zh active
-
2020
- 2020-03-04 JP JP2020036665A patent/JP7080268B2/ja active Active
- 2020-03-11 US US16/815,923 patent/US11020368B2/en active Active
- 2020-12-07 PH PH12020552112A patent/PH12020552112A1/en unknown
-
2021
- 2021-01-05 CY CY20211100004T patent/CY1123706T1/el unknown
- 2021-01-11 MX MX2023007091A patent/MX2023007091A/es unknown
- 2021-01-11 US US17/146,057 patent/US12186295B2/en active Active
- 2021-01-26 HR HRP20210138TT patent/HRP20210138T1/hr unknown
- 2021-03-29 US US17/216,195 patent/US12178793B2/en active Active
-
2022
- 2022-05-24 JP JP2022084562A patent/JP7397910B2/ja active Active
-
2023
- 2023-12-01 JP JP2023203763A patent/JP2024023498A/ja active Pending
-
2024
- 2024-11-15 US US18/949,815 patent/US20250073196A1/en active Pending
-
2025
- 2025-04-29 AU AU2025203019A patent/AU2025203019A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2023007091A (es) | Composiciones oftalmicas que contienen una prostamida liberadora de oxido nitrico. | |
| MA51204B1 (fr) | Formes pharmaceutiques comprenant un inhibiteur de la kallicréine plasmatique | |
| PH12020552154A1 (en) | Compounds | |
| WO2015070224A3 (en) | Combination therapy including an mdm2 inhibitor and one or more additional pharmaceutically active agents for the treatment of cancers | |
| MX2020001403A (es) | Nuevos derivados de quinolina. | |
| EP4663636A3 (en) | Trifluoromethyl substituted pyrazoles as human plasma kallikrein inhibitors | |
| MA42561A (fr) | Procédés de formulation de compositions de conjugués anticorps-médicament | |
| NZ721952A (en) | Delayed release compositions of linaclotide | |
| EA201590730A1 (ru) | Способ и стероидная композиция для местного применения | |
| CL2018003319A1 (es) | Compuestos de mic-1 y usos de estos. | |
| NZ748016A (en) | Use of cannabidiolic acid in the treatment of autism spectrum disorder and associated disorders | |
| WO2016130800A3 (en) | Pharmaceutical compositions comprising perillyl alcohol derivatives | |
| MX2019004859A (es) | Tratamientos de combinacion que comprenden la administracion de imidazopirazinonas. | |
| MX2019003685A (es) | Composicion farmaceutica para uso en el tratamiento terapeutico del cancer y complicaciones del cancer. | |
| ZA201901370B (en) | Formulations for oral administration of active agents | |
| MX2022000712A (es) | Moduladores de nlrp3. | |
| EA202191548A1 (ru) | Ингибиторы плазменного калликреина человека | |
| CL2019003533A1 (es) | Uso de vibegron para tratar vejiga sobreactiva. | |
| MX2020004981A (es) | Novedosos derivados de pirazolo-pirrolo-pirimidina como inhibidores de p2x3. | |
| PH12019500618A1 (en) | Pharmaceutical composition and method for treatment of non-alcoholic fatty liver disease | |
| JOP20190086A1 (ar) | مشتقات نافثيريدينون جديدة واستخدامها في معالجة عدم انتظام ضربات القلب | |
| WO2016001905A3 (en) | Stable liquid ready-to-use injectable formulation of bortezomib | |
| CL2019001338A1 (es) | Preparación cosmética de viscosidad mejorada para el tratamiento de las fibras queratínicas, proceso para el aumento de la viscosidad de una preparación cosmética, uso de ingredientes modificadores de la viscosidad y método de tratamiento de las fibras queratínicas. | |
| WO2016123392A3 (en) | Pyrazolopyrimidines as inhibitors of glucocorticoid receptor translocation | |
| TH2101000072A (th) | องค์ประกอบที่ใช้เฉพาะที่กับตาซึ่งมีพรอสตาไมด์ที่ปลดปล่อยไนตริกออกไซด์ |